Protein kinase C modulates insulin action in human skeletal muscle

American Journal of Physiology - Endocrinology and Metabolism

Volumn 278, Issue 3 41-3, 2000, Pages

  Cortright, Ronald N ^a   Azevedo Jr , John L ^a,b   Zhou, Qian ^a   Sinha, Madhur ^a   Pories, Walter J ^a   Itani, Samar I ^a   Dohm, G Lynis ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Diabetes; Glucose transport; Insulin resistance; Muscle; Non insulin dependent diabetes mellitus

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; DEOXYGLUCOSE; INSULIN; INSULIN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C;

ADIPOCYTE; ARTICLE; GENE ACTIVATION; GENE ACTIVITY; GENE CONTROL; GENE OVEREXPRESSION; GLUCOSE TRANSPORT; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN RESPONSE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SKELETAL MUSCLE;

EID: 0034020240     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.2000.278.3.e553     Document Type: Article

References (46)

1. Anderson, C. M., and J. M. Olefsky. Phorbol ester-mediated protein kinase C interaction with wild-type and COOH-terminal truncated insulin receptors. J. Biol. Chem. 266: 21760-21764, 1991.
2. Arner, P. T. Pollare, and J. N. Livingston. Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30: 437-440, 1987.
3. Avignon, A., K. Yamada, X. Zhou, B. Spencer, O. Cardona, S. Saba-Siddique, L. Galloway, M. L. Standaert, and R. V. Farese. Chronic activation of protein kinase C in soleus muscles and other tissues of insulin-resistant type II diabetic Goto-Kakizake (GK), obese/aged, and obese/Zucker rats. Diabetes 45: 1396-1404, 1996.
4. Azevedo, J. L., Jr., J. O. Carey, W. J. Pories, P. G. Morris, and G. L. Dohm. Hypoxia stimulates glucose transport in insulin resistant human skeletal muscle. Diabetes 44: 695-698, 1995.
5. Berti, L., L. Mosthaf, G. Kroder, M. Kellerer, S. Tippmer, J. Mushack, E. Seffe, K. Seedorf, and H. Haring. Glucose-induced translocation of protein kinase C isoforms in rat-1 fibroblasts is paralleled by inhibition of the insulin receptor tyrosine kinase. J. Biol. Chem. 269: 3381-3386, 1994.
6. Carey, J. O., J. L. Azevedo, Jr., P. G. Morris, W. J. Pories, and G. L. Dohm. Okadaic acid, vanadate, and phenylarsine oxide stimulate 2-deoxyglucose transport in insulin-resistant human skeletal muscle. Diabetes 44: 682-688, 1995.
7. Caro, J. F., M. K. Sinha, S. M. Raju, O. Ittoop, W. J. Pories, E. G. Flickinger, D. Meelheim, and G. L. Dohm. Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J. Clin. Invest. 79: 1330-1337, 1987.
8. Chen, K. S., S. Heydrick, T. Kurowski, and N. B. Ruderman. Diacylglycerol-protein kinase C signaling in skeletal muscle: a possible link to insulin resistance. Trans. Assoc. Am. Physicians 104: 206-212, 1991.
9. Chin, J. E., M. Dickens, J. M. Tavare, and R. A. Roth. Overexpression of protein kinase C isoenzymes α, β, γ, and ε in cells overexpressing the insulin receptor. Effects on receptor phosphorylation and signaling. J. Biol. Chem. 268: 6338-6347, 1993.
10. Chin, J. E., F. Liu, and R. A. Roth. Activation of protein kinase C inhibits insulin-stimulated tyrosine phosphorylation of insulin receptor substrate-1. Mol. Endocrinol. 8: 51-58, 1994.
11. Coghlan, M. P., T. S. Pillay, J. M. Tavare, and D. Siddle. Site-specific antiphosphopeptide antibodies: use in assessing insulin receptor serine/threonine phosphorylation state and identification of serine-1327 as a novel site of phorbol ester-induced phosphorylation. Biochem. J. 303: 893-899, 1994.
12. Considine, R. V., and J. F. Caro. Protein kinase C: mediator or inhibitor of insulin action? J. Cell Biochem. 52: 8-13, 1993.
13. Considine, R. V., M. R. Nyce, L. E. Allen, L. M. Morales, S. Triester, J. Serrano, J. Colberg, S. Lanza-Jacoby, and Jose F. Caro. Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: an alteration not due to hyperglycemia. J. Clin. Invest. 95: 2938-2944, 1995.
14. Cooper, D. R., J. E. Watson, and M. L. Dao. Decreased expression of protein kinase-Cα, β, and ε in soleus muscle of Zucker obese (fa/fa) rats. Endocrinology 133: 2241-2247, 1993.
15. Danielsen, A. G., F. Liu, Y. Hosomi, K. Shii, and R. A. Roth. Activation of protein kinase C α inhibits signaling by members of the insulin receptor family. J. Biol. Chem. 270: 21600-21605, 1995.
16. Dohm, G. L., E. B. Tapscott, W. J. Pories, D. J. Dabbs, E. G. Flickinger, D. Meelheim, T. Fushiki, S. M. Atkinson, C. W. Elton, and J. F. Caro. An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J. Clin. Invest. 82: 486-494, 1988.
17. Donnelly, R., and X. Qu. Mechanisms of insulin resistance and new pharmacological approaches to metabolism and diabetic complications. Clin. Exp. Pharmacol. Physiol. 25: 79-87, 1997.
18. Donnelly, R., M. J. Reed, S. Azhar, and G. M. Reaven. Expression of the major isoenzyme of protein kinase-C in skeletal muscle, PKC 0, varies with muscle type and in response to fructose-induced insulin resistance. Endocrinology 135: 2369-2374, 1994.
19. Dunaif, A., J. Xia, C.-B. Book, E. Schenker, and Z. Tang. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J. Clin. Invest. 96: 801-810, 1995.
20. Elton, C. W., E. B. Tapscott, W. J. Pories, and G. L. Dohm. Effect of moderate obesity on glucose transport in human muscle. Horm. Metab. Res. 26: 180-182, 1994.
21. Farese, R. V. Protein Kinase C in Insulin Action, Resistance and Secretion. Austin, TX: Landes, 1994.
22. Feener, E. P., T. Shiba, K.-Q. Hu, P. A. Wilden, M. F. White, and G. L. King. Characterization of phorbol ester-stimulated serine phosphorylation of the human insulin receptor. Biochem. J. 303: 43-50, 1994.
23. Friedman, J. E., J. F. Caro, W. J. Pories, J. L. Azevedo, and G. L. Dohm. Glucose metabolism in incubated human muscle: effect of obesity and non-insulin dependent diabetes mellitus. Metabolism 43: 1047-1054, 1994.
24. Goodyear, L. J., F. Giorgino, L. A. Sherman, J. Carey, R. J. Smith, and G. L. Dohm. Insulin receptor phosphorylation, IRS-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J. Clin. Invest. 95: 2195-2204, 1995.
25. Griffin, M. E., M. J. Marcucci, G. W. Cline, K. Bell, N. Barucci, D. Lee, L. J. Goodyear, E. W. Kraegen, M. F. White, and G. I. Shulman. Free fatty acids-induced insulin resistance is associated with activation of protein kinase C θ and alterations in the insulin signaling cascade. Diabetes 48: 1270-1274, 1999.
26. Gschwendt, M., H. J. Muller, K. Kielbassa, R. Zang, W. Kittstein, G. Rincke, and F. Marks. Rottlerin, a novel protein kinase inhibitor. Biochem. Biophys. Res. Commun. 199: 93-98, 1994.
27. Hansen, P.A., J. A. Corbett, and J. O. Holoszy. Phorbol esters stimulate muscle glucose transport by a mechanism distinct from the insulin and hypoxia pathways. Am. J. Physiol. Endocrinol. Metab. 273: E28-E36, 1997.
28. Heydrick, S. J., N. Gautier, C. Olichon-Berthe, E. van Obberghen, and Y. Le Marchand-Brustel. Early alteration of insulin stimulation of PI 3-kinase in muscle and adipocyte from gold thioglucose obese mice. Am. J. Physiol. Endocrinol. Metab. 268: E604-E612, 1995.
29. Hotamisligil, G. S., P. Peraldi, A. Budavari, R. Ellis, M. F. White, and B. M. Spiegelman. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance. Science 271: 665-668, 1996.
30. Kashlwagl, M., A. Verso, J. Andrews, B. Vasquez, G. Reaven, and J. E. Foley. In vitro insulin resistance of human adipocyte isolated from subjects with non-insulin dependent diabetes mellitus. J. Clin. Nutr. 72: 1246-1254, 1983.
31. Lam, K., C. L. Carpenter, N. B. Ruderman, J. C. Friel, and K. L. Kelly. The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1. Stimulation by insulin and inhibition by wortmannin. J. Biol. Chem. 269: 20648-20652, 1994.
32. Lee, J., and P. F. Pilch. The insulin receptor: structure, function, and signaling. Am. J. Physiol. Cell Physiol. 266: C319-C334 1994
33. Lewis, R. E., D. J. Volle, and S. D. Sanderson. Phorbol ester stimulates phosphorylation of serine 1327 of the human insulin receptor. J. Biol. Chem. 269: 26259-26266, 1994.
34. Liu, F., and R. A. Roth. Identification of serines-1035/1037 in the kinase domain of the insulin receptor as protein kinase C mediated phosphorylation sites. FEBS Lett. 352: 389-392, 1994.
35. Muller, H. K., M. Kellerer, B. Ermel, A. Muhlhofer, B. Obermaier-Kusser, B. Vogt, and H. U. Haring. Prevention by protein kinase C inhibitors of glucose-induced insulin-receptor tyrosine kinase resistance in rat fat cells. Diabetes 40: 1440-1448, 1991.
36. Obermaier-Kusser, B., M. F. White, D. E. Pongratz, Z. Su, B. Ermel, C. Muhlbacher, and H. U. Haring. A defective intramolecular autoactivation cascade may cause the reduced kinase activity of the skeletal muscle insulin receptor from patients with non-insulin-dependent diabetes mellitus. J. Biol. Chem. 264: 9497-9504, 1989.
37. Quenpmeier, A., H. Daneschmand, H. Klein, K. Unthan-Fechner, and I. Probst. Insulin-mimetic actions of phorbol ester in cultured adult rat hepatocytes: lack of phorbol esterelicited inhibition of the insulin signal. Biochem. J. 289: 549-555, 1993.
38. Sale, G. J. Serine/threonine kinases and tyrosine phosphatases that act on the insulin receptor. Biochem. Soc. Trans. 20: 664-668, 1992.
39. Schmitz-Peiffer, C., N. D. Oakes, C. L. Browne, E. W. Kraegen, and T. J. Biden. Reversal of chronic alterations of skeletal muscle protein kinase C from fat-fed rats by BRL-49653. Am. J. Physiol. Endocrinol. Metab. 273: E915-E921, 1997.
40. Shmueli, E., K. G. M. Alberti, and C. O. Record. Diacylglycerol/ protein kinase C signaling: a mechanism for insulin resistance? J. Int. Med. 234: 397-400, 1993.
41. Sinha, M. K., L. G. Taylor, W. J. Pories, E. G. Flickinger, D. Meelheim, S. Atkinson, N. S. Sehgal, and J. F. Caro. Long term effect of insulin on glucose transport and insulin binding in cultured adipocytes from normal and obese humans with or without non-insulin dependent diabetes mellitus. J. Clin. Invest. 80: 1073-1081, 1987.
42. Stadtmauer, L., and O. M. Rosen. Increasing the cAMP content of IM-9 cells alters the phosphorylation state and protein kinase activity of the insulin receptor. Biochem. J. 250: 509-519, 1986.
43. Takayama, S., M. F. White, and C. R. Kahn. Phorbol esterinduced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity. J. Biol. Chem. 263: 3440-3447, 1988.
44. Tanti, J. F., T. Gremeaux, E. Van Obberghen, and Y. Le Marchand-Brustel. Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. J. Biol. Chem. 269: 6051-6057, 1994.
45. Toullec, D., P. Pianetti, H. Coste, P. Bellevergue, T. Grand-Perret, M. Ajakane, V. Baudet, P. Boissin, E. Boursier, F. Loriolle, L. Duhamel, D. Charon, and J. Kirilovsky. The bisindolylmaleimide GF-109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266: 15771-15781, 1991.
46. Zhou, Q., P. L. Dolan, and G. L. Dohm. Dephosphorylation increases insulin-stimulated receptor kinase activity in skeletal muscle of obese Zucker rats. Mol. Cell. Biochem. 194: 209-216, 1999.